Differences in virulence among porcine circovirus type 2 isolates are unrelated to cluster type 2a or 2b and prior infection provides heterologous protection
Porcine circovirus type 2 (PCV2) is divided into two genetic clusters designated PCV2a and PCV2b. The objectives of this study were to determine whether isolates from different clusters vary in virulence and to determine whether infection with PCV2a isolates induces protective immunity against subsequent infection with a recent PCV2b isolate. One-hundred and thirteen conventional specific-pathogen-free (SPF) pigs were assigned randomly to treatment groups and rooms: pigs inoculated with PCV2a cluster isolates (ISU-40895 or ISU-4838), pigs inoculated with PCV2b cluster isolates (NC-16845 or Can-17639) and uninoculated pigs. Necropsies were performed at 16 or 51 days post-inoculation (p.i.). There were no significant differences in PCV2-associated lymphoid lesions between PCV2a and PCV2b clusters; however, within the same cluster, significant differences were found between isolates: ISU-4838- and Can-17639-inoculated pigs had significantly (P<0.05) less severe lesions compared with ISU-40895- and NC-16845-inoculated pigs. To evaluate cross-protection, six pigs within each group were challenged at 35 days p.i. with an isolate from the heterologous cluster and were necropsied 51 days p.i. The severity of PCV2-associated lesions was reduced in pigs with prior exposure to an isolate from the heterologous cluster in comparison with singly inoculated pigs. Results indicate that the virulence of PCV2a and PCV2b isolates is not different in the conventional SPF pig model; however, the virulence of isolates within the same cluster differs. Increased virulence as reported to be associated with PCV2b isolates in the field was not observed under the conditions of this study. Moreover, cross-protection between PCV2a and PCV2b exists.
AllanG. M.,
McNeillyF.,
McNairI.,
MeehanB.,
MarshallM.,
EllisJ.,
LasagnaC.,
BoriosiG.,
KrakowkaS.other authors2002; Passive transfer of maternal antibodies to PCV2 protects against development of post-weaning multisystemic wasting syndrome (PMWS): experimental infections and a field study. Pig J 50:59–67
BereiterM.,
YoungT. F.,
JooH. S.,
RossR. F.1990; Evaluation of the ELISA and comparison to the complement fixation test and radial immunodiffusion enzyme assay for detection of antibodies against Mycoplasma hyopneumoniae in swine serum. Vet Microbiol 25:177–192[CrossRef]
CarmanS.,
McEwenB.,
DeLayJ.,
van DreumelT.,
LusisP.,
CaiH.,
FairlesJ.2006; Porcine circovirus-2 associated disease in swine in Ontario (2004 to 2005. Can Vet J 47:761–762
CheungA. K.,
LagerK. M.,
KohutyukO. I.,
VincentA. L.,
HenryS. C.,
BakerR. B.,
RowlandR. R.,
DunhamA. G.2007; Detection of two porcine circovirus type 2 genotypic groups in United States swine herds. Arch Virol 152:1035–1044[CrossRef]
de BoissesonC.,
BevenV.,
BigarreL.,
ThieryR.,
RoseN.,
EvenoE.,
MadecF.,
JestinA.2004; Molecular characterization of porcine circovirus type 2 isolates from post-weaning multisystemic wasting syndrome-affected and non-affected pigs. J Gen Virol 85:293–304[CrossRef]
DupontK.,
NielsenE. O.,
BaekboP.,
LarsenL. E.2008; Genomic analysis of PCV2 isolates from Danish archives and a current PMWS case-control study supports a shift in genotypes with time. Vet Microbiol 128:56–64[CrossRef]
FenauxM.,
HalburP. G.,
GillM.,
TothT. E.,
MengX. J.2000; Genetic characterization of type 2 porcine circovirus (PCV-2) from pigs with postweaning multisystemic wasting syndrome in different geographic regions of North America and development of a differential PCR-restriction fragment length polymorphism assay to detect and differentiate between infections with PCV-1 and PCV-2. J Clin Microbiol 38:2494–2503
FenauxM.,
HalburP. G.,
HaqshenasG.,
RoyerR.,
ThomasP.,
NawagitgulP.,
GillM.,
TothT. E.,
MengX. J.2002; Cloned genomic DNA of type 2 porcine circovirus is infectious when injected directly into the liver and lymph nodes of pigs: characterization of clinical disease, virus distribution, and pathologic lesions. J Virol 76:541–551[CrossRef]
FenauxM.,
OpriessnigT.,
HalburP. G.,
MengX. J.2003; Immunogenicity and pathogenicity of chimeric infectious DNA clones of pathogenic porcine circovirus type 2 (PCV2) and nonpathogenic PCV1 in weanling pigs. J Virol 77:11232–11243[CrossRef]
FenauxM.,
OpriessnigT.,
HalburP. G.,
ElvingerF.,
MengX. J.2004a; A chimeric porcine circovirus (PCV) with the immunogenic capsid gene of the pathogenic PCV type 2 (PCV2) cloned into the genomic backbone of the nonpathogenic PCV1 induces protective immunity against PCV2 infection in pigs. J Virol 78:6297–6303[CrossRef]
FenauxM.,
OpriessnigT.,
HalburP. G.,
ElvingerF.,
MengX. J.2004b; Two amino acid mutations in the capsid protein of type 2 porcine circovirus (PCV2) enhanced PCV2 replication in vitro and attenuated the virus in vivo . J Virol 78:13440–13446[CrossRef]
FortM.,
SibilaM.,
AllepuzA.,
MateuE.,
RoerinkF.,
SegalésJ.2008; Porcine circovirus type 2 (PCV2) vaccination of conventional pigs prevents viremia against PCV2 isolates of different genotypes and geographic origins. Vaccine 26:1063–1071[CrossRef]
GagnonC. A.,
TremblayD.,
TijssenP.,
VenneM. H.,
HoudeA.,
ElahiS. M.2007; The emergence of porcine circovirus 2b genotype (PCV-2b) in swine in Canada. Can Vet J 48:811–819
Grau-RomaL.,
CrisciE.,
SibilaM.,
López-SoriaS.,
NofrariasM.,
CorteyM.,
FraileL.,
OlveraA.,
SegalésJ.2008; A proposal on porcine circovirus type 2 (PCV2) genotype definition and their relation with postweaning multisystemic wasting syndrome (PMWS) occurrence. Vet Microbiol 128:23–35[CrossRef]
HorlenK. P.,
SchneiderP.,
AndersonJ.,
NietfeldJ. C.,
HenryS. C.,
TokachL. M.,
RowlandR. R.2007; A cluster of farms experiencing severe porcine circovirus associated disease: clinical features and association with the PCV2b genotype. J Swine Health Prod 15:270–278
LagerK. M.,
GaugerP. C.,
VincentA. L.,
OpriessnigT.,
KehrliM. E.Jr,
CheungA. K.2007; Mortality in pigs given porcine circovirus type 2 subgroup 1 and 2 viruses derived from DNA clones. Vet Rec 161:428–429[CrossRef]
LarochelleR.,
MagarR.,
D'AllaireS.2002; Genetic characterization and phylogenetic analysis of porcine circovirus type 2 (PCV2) strains from cases presenting various clinical conditions. Virus Res 90:101–112[CrossRef]
LarochelleR.,
MagarR.,
D'AllaireS.2003; Comparative serologic and virologic study of commercial swine herds with and without postweaning multisystemic wasting syndrome. Can J Vet Res 67:114–120
LefebvreD. J.,
CostersS.,
Van DoorsselaereJ.,
MisinzoG.,
DelputteP. L.,
NauwynckH. J.2008; Antigenic differences among porcine circovirus type 2 strains, as demonstrated by the use of monoclonal antibodies. J Gen Virol 89:177–187[CrossRef]
LiuQ.,
WangL.,
WillsonP.,
O'ConnorB.,
KeenlisideJ.,
Chirino-TrejoM.,
MelendezR.,
BabiukL.2002; Seroprevalence of porcine circovirus type 2 in swine populations in Canada and Costa Rica. Can J Vet Res 66:225–231
MankertzA.,
DomingoM.,
FolchJ. M.,
LeCannP.,
JestinA.,
SegalésJ.,
ChmielewiczB.,
Plana-DuránJ.,
SoikeD.2000; Characterisation of PCV-2 isolates from Spain, Germany and France. Virus Res 66:65–77[CrossRef]
McKeownN. E.,
OpriessnigT.,
ThomasP.,
GuenetteD. K.,
ElvingerF.,
FenauxM.,
HalburP. G.,
MengX. J.2005; Effects of porcine circovirus type 2 (PCV2) maternal antibodies on experimental infection of piglets with PCV2. Clin Diagn Lab Immunol 12:1347–1351
MeertsP.,
Van GuchtS.,
CoxE.,
VandeboschA.,
NauwynckH. J.2005; Correlation between type of adaptive immune response against porcine circovirus type 2 and level of virus replication. Viral Immunol 18:333–341[CrossRef]
MeertsP.,
MisinzoG.,
LefebvreD.,
NielsenJ.,
BøtnerA.,
KristensenC. S.,
NauwynckH. J.2006; Correlation between the presence of neutralizing antibodies against porcine circovirus 2 (PCV2) and protection against replication of the virus and development of PCV2-associated disease. BMC Vet Res 2:6[CrossRef]
MengelingW. L.,
RidpathJ. F.,
VorwaldA. C.1988; Size and antigenic comparisons among the structural proteins of selected autonomous parvoviruses. J Gen Virol 69:825–837[CrossRef]
MorozovI.,
SirinarumitrT.,
SordenS. D.,
HalburP. G.,
MorganM. K.,
YoonK. J.,
PaulP. S.1998; Detection of a novel strain of porcine circovirus in pigs with postweaning multisystemic wasting syndrome. J Clin Microbiol 36:2535–2541
NawagitgulP.,
HarmsP. A.,
MorozovI.,
ThackerB. J.,
SordenS. D.,
LekcharoensukC.,
PaulP. S.2002; Modified indirect porcine circovirus (PCV) type 2-based and recombinant capsid protein (ORF2)-based enzyme-linked immunosorbent assays for detection of antibodies to PCV. Clin Diagn Lab Immunol 9:33–40
OpriessnigT.,
YuS.,
GallupJ. M.,
EvansR. B.,
FenauxM.,
PallaresF.,
ThackerE. L.,
BrockusC. W.,
AckermannM. R.other authors2003; Effect of vaccination with selective bacterins on conventional pigs infected with type 2 porcine circovirus. Vet Pathol 40:521–529[CrossRef]
OpriessnigT.,
FenauxM.,
YuS.,
EvansR. B.,
CavanaughD.,
GallupJ. M.,
PallaresF. J.,
ThackerE. L.,
LagerK. M.other authors2004a; Effect of porcine parvovirus vaccination on the development of PMWS in segregated early weaned pigs coinfected with type 2 porcine circovirus and porcine parvovirus. Vet Microbiol 98:209–220[CrossRef]
OpriessnigT.,
ThackerE. L.,
YuS.,
FenauxM.,
MengX. J.,
HalburP. G.2004b; Experimental reproduction of postweaning multisystemic wasting syndrome in pigs by dual infection with Mycoplasma hyopneumoniae and porcine circovirus type 2. Vet Pathol 41:624–640[CrossRef]
OpriessnigT.,
HalburP. G.,
YuS.,
ThackerE. L.,
FenauxM.,
MengX. J.2006b; Effects of the timing of the administration of Mycoplasma hyopneumoniae bacterin on the development of lesions associated with porcine circovirus type 2. Vet Rec 158:149–154[CrossRef]
OpriessnigT.,
McKeownN. E.,
ZhouE. M.,
MengX. J.,
HalburP. G.2006c; Genetic and experimental comparison of porcine circovirus type 2 (PCV2) isolates from cases with and without PCV2-associated lesions provides evidence for differences in virulence. J Gen Virol 87:2923–2932[CrossRef]
PogranichnyyR. M.,
YoonK. J.,
HarmsP. A.,
SwensonS. L.,
ZimmermanJ. J.,
SordenS. D.2000; Characterization of immune response of young pigs to porcine circovirus type 2 infection. Viral Immunol 13:143–153[CrossRef]
SordenS. D.,
HarmsP. A.,
NawagitgulP.,
CavanaughD.,
PaulP. S.1999; Development of a polyclonal-antibody-based immunohistochemical method for the detection of type 2 porcine circovirus in formalin-fixed, paraffin-embedded tissue. J Vet Diagn Invest 11:528–530[CrossRef]
ToddD.,
BendinelliM.,
BiaginiP.,
HinoS.,
MankertzA.,
MishiroS.,
NielC.,
OkamotoH.,
RaidalS.other authors2005; Family Circoviridae . In Virus Taxonomy. Eighth Report of the International Committee on Taxonomy of Viruses pp 327–334Edited byFauquetC. M.,
MayoM. A.,
ManiloffJ.,
DesselbergerU.,
BallL. A.
San Diego: Elsevier Academic Press;
VigreH.,
BaekboP.,
JorsalS. E.,
Bille-HansenV.,
HassingA. G.,
EnøeC.,
BøtnerA.2005; Spatial and temporal patterns of pig herds diagnosed with postweaning multisystemic wasting syndrome (PMWS) during the first two years of its occurrence in Denmark. Vet Microbiol 110:17–26[CrossRef]
WalkerI. W.,
KonobyC. A.,
JewhurstV. A.,
McNairI.,
McNeillyF.,
MeehanB. M.,
CottrellT. S.,
EllisJ. A.,
AllanG. M.2000; Development and application of a competitive enzyme-linked immunosorbent assay for the detection of serum antibodies to porcine circovirus type 2. J Vet Diagn Invest 12:400–405[CrossRef]
Differences in virulence among porcine circovirus type 2 isolates are unrelated to cluster type 2a or 2b and prior infection provides heterologous protection